A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2018; you can also visit the original URL.
The file type is
Int J Clin Exp Med
Objective: This study was to compare the pathological changes and postoperative survival time between patients with Budd-Chiari syndrome (B-CS) associated hepatocellular carcinoma (HCC) and those with hepatitis B virus (HBV) associated HCC. Methods: 15 B-CS-associated HCC and 30 HBV-associated HCC patients undergoing operation were analyzed. Results: The average Ki67 index of B-CS-associated HCC group (19.7±14.2) was significantly lower than that of HBV-associated HCC group (31.2±18.0)fatcat:bns5imlkgves3flxsgmctahjke